Linden Thomas Advisory Services’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,917
Closed -$989K 548
2026
Q1
$989K Buy
18,917
+763
+4% +$45.8K 0.1% 318
2025
Q4
$1.07M Sell
18,154
-822
-4% -$49.9K 0.11% 284
2025
Q3
$1.06M Sell
18,976
-186
-1% -$9.96K 0.11% 284
2025
Q2
$986K Sell
19,162
-193
-1% -$9.7K 0.11% 286
2025
Q1
$1.13M Buy
19,355
+569
+3% +$38.6K 0.15% 250
2024
Q4
$1.35M Sell
18,786
-287
-2% -$21.1K 0.17% 222
2024
Q3
$1.52M Sell
19,073
-133
-0.7% -$9.99K 0.21% 188
2024
Q2
$1.38M Sell
19,206
-10,955
-36% -$806K 0.21% 198
2024
Q1
$2.12M Buy
30,161
+1,720
+6% +$123K 0.34% 80
2023
Q4
$2.19M Buy
28,441
+899
+3% +$59.2K 0.41% 54
2023
Q3
$1.87M Buy
27,542
+8,298
+43% +$656K 0.42% 53
2023
Q2
$1.57M Buy
19,244
+407
+2% +$32.7K 0.35% 92
2023
Q1
$1.4M Buy
18,837
+1,607
+9% +$124K 0.35% 114
2022
Q4
$1.43M Buy
+17,230
New +$1.37M 0.4% 88

Other funds holding TECH

Linden Thomas Advisory Services's TECH Position: Q2 2026 in Review

Linden Thomas Advisory Services sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 18,917 shares — an estimated $989K sold.

Linden Thomas Advisory Services first reported a position in TECH in Q4 2022 and held it in 14 quarters. The position peaked at $2.19M in Q4 2023. 117 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Linden Thomas Advisory Services reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Linden Thomas Advisory Services sold 18,917 Bio-Techne shares in Q2 2026, an estimated $989K.
  • Linden Thomas Advisory Services first reported a position in Bio-Techne in Q4 2022 and held it in 14 quarters.
  • Linden Thomas Advisory Services's Bio-Techne position peaked at $2.19M in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.